Iguchi Kimi - Nov 28, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Nov 28, 2023
Transactions value $
-$18,172
Form type
4
Date filed
11/30/2023, 04:04 PM
Previous filing
Mar 17, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +3.5K +5.28% $0.00 69.7K Nov 28, 2023 Direct F1, F2
transaction SAGE Common Stock Tax liability -$18.2K -943 -1.35% $19.27 68.8K Nov 28, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 8,750 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 3,500 shares.
F2 Reflects beneficial ownership balance which includes 670 shares purchased on June 30, 2023 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.